Acta Scientific Nutritional Health (ASNH)(ISSN: 2582-1423)

Mini Review Volume 4 Issue 7

A Mini-Review on an Association between Nutrition and Mucosal Immunity in the Midst of the COVID-19 Pandemic

Kyoka Matsubayashi1, Minami Yoshiike1 and Yuji Aoki2*

1Department of Health and Nutritional Science, Matsumoto University, Japan
2Matsumoto University Graduate School of Health Science, Japan

*Corresponding Author: Yuji Aoki, Matsumoto University Graduate School of Health Science, Japan.

Received: May 13, 2020; Published: June 18, 2020



 In the midst of the COVID-19 pandemic, which the World Health Organization officially declared a pandemic on March 11, 2020, we write a mini-review on an association between nutrition and mucosal immunity. The human immunity consists of non-specific innate immunity recognizing pathogen-associated molecular patterns and subsequent adaptive immunity specific for the target antigens. The immune system of the intestine as mucosal immunity must have functions to defend against constant threat of invading pathogens while suppressing immune responses to harmless dietary antigens and commensal bacteria. Nutrition seems to have a major role in non-heritable influences on the innate and adaptive immunity. It has been demonstrated in humans that some nutrients including β-glucan have the potential to boost the mucosal immunity to viral infections. Conversely, it is conceivable that continuing supplementation of (large-dose) β-glucans or lipopolysaccharides can suppress the innate immunity by stimulating regulatory T cells. For now, the impact of nutrition on human immunity should neither be overestimated nor be underestimated.

Keywords: Nutrition; Innate Immunity; Adaptive Immunity; Mucosal Immunity; COVID-19



  1. Zhu N., et al. “A novel coronavirus from patients with pneumonia in China, 2019”. The New England Journal of Medicine8 (2020): 727-733.
  2. Grasselli G., et al. “Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy”. Journal of the American Medical Association (2020).
  3. Bedford J., et al. “COVID-19: towards controlling of a pandemic”. The Lancet10229 (2020): 1015-1018.
  4. Chaplin D.D. “Overview of the immune response”. Journal of Allergy and Clinical Immunology2 (2010): S3-S23.
  5. McDade T.W., et al. “Trade-offs between acquired and innate immune defenses in humans”. Evolution, Medicine, and Public Health (2016). 1-16.
  6. Thevarajan I., et al. “Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19”. Nature Medicine (2020).
  7. Segerstrom S.C., et al. “Stress, energy, and immunity: an ecological view”. Current Directions in Psychological Science 16.6 (2007): 326-330.
  8. Hiemstra PS. “The role of epithelial beta-defensins and cathelicidins in host defense of the lung”. Experimental Lung Research10 (2007): 537-542.
  9. Mogensen T.H., et al. “Pathogen recognition and inflammatory signaling in innate immune defenses”. Clinical Microbiology Reviews2 (2009): 240-273.
  10. Panda S.K., et al. “Innate lymphoid cells in mucosal immunity”. Frontiers in Immunology 10 (2019): 861.
  11. Saeed F., et al. “Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds - a review”. Food and Agricultural Immunology2 (2016): 205-229.
  12. Dillon A., et al. “M cells: intelligent engineering of mucosal immune surveillance”. Frontiers in Immunology 10 (2019): 1499.
  13. Kobayashi N., et al. “The roles of Peyer’s patches and microfold cells in the gut immune system: relevance to autoimmune diseases”. Frontiers in Immunology 10 (2019): 2345.
  14. Tanoue T., et al. “Development and maintenance of intestinal regulatory T cells”. Nature Reviews Immunology5 (2016): 295-309.
  15. Wu H.-J., et al. “The role of gut microbiota in immune homeostasis and autoimmunity”. Gut Microbes 1 (2012): 4-14.
  16. Lee K.H., et al. “The gut microbiota, environmental factors, and links to the development of food allergy”. Clinical and Molecular Allergy 18 (2020): 5.
  17. Samuelson D.R., et al. “Regulation of lung immunity and host defense by the intestinal microbiota”. Frontiers in Microbiology 6 (2015): 1085.
  18. Li N., et al. “The commensal microbiota and viral infection: a comprehensive review”. Frontiers in Immunology 10 (2019): 1551.
  19. Kikkert M. “Innate immune evasion by human respiratory RNA viruses”. Journal of Innate Immunity 12 (2020): 4-20.
  20. Xia J., et al. “Convergence of longevity and immunity: lessons from animal models”. Biogerontology 3 (2019): 271-278.
  21. Brodin P., et al. “Human immune system variation”. Nature Reviews Immunology1 (2017): 21-29.
  22. Schaible U.E., et al. “Malnutrition and infection: complex mechanism and global impacts”. PLoS Medicine5 (2007): e115.
  23. Cereda E., et al. “The association of geriatric nutritional risk index and total lymphocyte count with short-term nutrition-related complications in institutionalized elderly”. Journal of the American College of Nutrition 3 (2008): 406-413.
  24. Mora J.R., et al. “Vitamin effects on the immune system: vitamins A and D take centre stage”. Nature Review Immunology9 (2008): 685-698.
  25. Hemila H., et al. “Vitamin C for preventing and treating the common cold”. Cochrane Database of Systematic Reviews (2013): CD000980.
  26. Martineau AR., et al. “Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data”. British Medical Journal 356 (2017): i6583.
  27. Li Y., et al. “Quercetin, inflammation and immunity”. Nutrients3 (2016): 167.
  28. Furushima D., et al. “Prevention of acute upper respiratory infections by consumption of catechins in healthcare workers: a randomized, placebo-controlled trial”. Nutrients1 (2020): 4.
  29. Kartasurya M.I., et al. “Zinc combined with vitamin A reduces upper respiratory tract infection morbidity in preschool children in Indonesia”. British Journal of Nutrition 12 (2012): 2251-2260.
  30. Richter J., et al. “β-glucan affects mucosal immunity in children with chronic respiratory problems under physical stress: clinical trials”. Annals of Translational Medicine4 (2015): 52.
  31. Vetvicka V., et al. “Placebo-driven clinical trials of yeast-derived β-(1,3) glucan in children with chronic respiratory problems”. Annals of Translational Medicine3 (2013): 26.
  32. Man W.H., et al. “The microbiota of the respiratory tract: gatekeeper to respiratory health”. Nature Reviews Microbiology 5 (2017): 259-270.
  33. Schlake T., et al. “Developing mRNA-vaccine technologies”. RNA Biology 11 (2012): 1319-1330.
  34. Zhang C., et al. “Advances in mRNA vaccines for infectious diseases”. Frontiers in Immunology 10 (2019): 594.
  35. D’Elia R.V., et al. “Targeting the “cytokine storm” for the therapeutic benefit”. Clinical and Vaccine Immunology3 (2013): 319-327.
  36. Redelman-Sidi G. “Could BCG be used to protect against COVID-19?” Nature Reviews Urology (2020).


Citation: Yuji Aoki., et al. “A Mini-Review on an Association between Nutrition and Mucosal Immunity in the Midst of the COVID-19 Pandemic". Acta Scientific Nutritional Health 4.7 (2020): 43-48.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.316

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US